Medicine & Life Sciences
Biological Availability
23%
Caloric Restriction
32%
Cardiac Myocytes
24%
Comorbidity
20%
Cyclic GMP
59%
Diuretics
25%
Drive
26%
Equipment and Supplies
15%
Exercise
16%
Fibrosis
38%
Heart Failure
75%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
25%
Hypertension
16%
Inflammation
45%
Kidney
13%
Left Ventricular Dysfunction
55%
Lung
13%
Macrophages
18%
Muscle Weakness
54%
Neprilysin
33%
Nitrates
28%
Nitric Oxide
41%
Nitrites
28%
Paracrine Communication
36%
Phenotype
62%
Phosphodiesterase 5 Inhibitors
33%
Phosphoric Diester Hydrolases
29%
Psychological Inhibition
42%
Psychology Retention
56%
Pulmonary Hypertension
51%
Renal Insufficiency
22%
Skeletal Muscle
20%
Sodium
43%
Spironolactone
32%
Therapeutics
8%
Treatment Failure
100%
Ventricular Remodeling
30%